ETCM
RVNC
Evolutionary Tree Capital Management’s Revance Therapeutics, Inc. RVNC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-59,411
| Closed | -$1.5M | – | 37 |
|
|
2023
Q2 | $1.5M | Sell |
59,411
-7,414
| -11% | -$188K | 1.81% | 20 |
|
|
2023
Q1 | $2.15M | Sell |
66,825
-113,829
| -63% | -$3.67M | 2.98% | 13 |
|
|
2022
Q4 | $3.33M | Sell |
180,654
-11,214
| -6% | -$207K | 3.2% | 13 |
|
|
2022
Q3 | $5.18M | Buy |
191,868
+57,680
| +43% | +$1.56M | 4.98% | 6 |
|
|
2022
Q2 | $1.85M | Sell |
134,188
-42,148
| -24% | -$582K | 2.02% | 25 |
|
|
2022
Q1 | $3.44M | Sell |
176,336
-72,197
| -29% | -$1.41M | 2.39% | 22 |
|
|
2021
Q4 | $4.06M | Buy |
248,533
+81,342
| +49% | +$1.33M | 1.95% | 24 |
|
|
2021
Q3 | $4.66M | Buy |
167,191
+12,476
| +8% | +$348K | 2.07% | 23 |
|
|
2021
Q2 | $4.59M | Buy |
154,715
+4,702
| +3% | +$139K | 2.12% | 22 |
|
|
2021
Q1 | $4.19M | Buy |
150,013
+60,665
| +68% | +$1.7M | 2.48% | 20 |
|
|
2020
Q4 | $2.53M | Buy |
+89,348
| New | +$2.53M | 1.93% | 22 |
|